PLSE Pulse Biosciences Inc

Pulse Biosciences Inc is a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES for biomedical applications.

$20.33  -0.44 (-2.12%)
As of 11/30/2021 15:39:48 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  05/18/2016
Outstanding shares:  29,631,283
Average volume:  44,031
Market cap:   $641,220,964
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74587B101
ISIN:        US74587B1017
Sedol:      BD02SG8
Valuation   (See tab for details)
PE ratio:   -21.96
PB ratio:   12.99
PS ratio:   932.01
Return on equity:   -130.82%
Net income %:   -9,010.76%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy